Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Study Ties Mediterranean Diet to 30 Percent Risk Reduction for Diabetes in Women

Examining several biomarkers to look for biological explanations for these results, the research team found key mechanisms, including insulin resistance, body mass index (BMI), lipoprotein metabolism, and inflammation, according to the study authors.

Inclisiran Found to Be Well-tolerated and Effective for Hyperlipidemia in Adults

Results from 2 pooled post-hoc analyses of phase 3 ORION-9, -10, and -11 trials evaluating inclisiran demonstrated the treatment was well-tolerated and effective.

Research Suggests Most Humans Vulnerable to Type 2 Diabetes

Biological processes may be limiting the ability of insulin to adapt to obesity, rendering most people vulnerable to type 2 diabetes.

National Diabetes Prevention Program in Underserved Areas to Expand

Through Project IMPACT: Diabetes Prevention, the APhA Foundation has built the infrastructure that allows the National DPP to be offered using an innovative service model.

Combo Drug Treatment for Type 2 Diabetes Remains Effective After 2 Years

The drug combination of dapagliflozin and exenatide continues to stay effective without a loss of effect after 2 years of continual use in patients with type 2 diabetes (T2D), according to researchers at Thomas Jefferson University.

Study: Glucose-Lowering Drugs Have Neutral Impact on COVID-19 Mortality

Further research is essential in order to determine the relationship between diabetes and COVID-19 and what impact glucose-lowering drugs may have.

Insulin Pumps Improve Diabetes Management

For patients with type 1 and type 2 diabetes, these computerized devices offer a break from conventional daily injections, while allowing patients to still reach and maintain their A1c levels and blood sugar targets.

New Pet Glucose Monitoring System Arriving in Pharmacies

Dogs and Cats have different blood make-ups and need a specifically calibrated device for glucose monitoring to manage diabetes.

Weight Loss Surgery in Obese Diabetic Patients Significantly Cuts Pancreatic Cancer Risk

The research found that obese patients with diabetes were significantly less likely to develop pancreatic cancer if they had undergone bariatric surgery, with the majority of the patients in the study being female.

US Insulin Prices Drastically Higher than Other High-Income Countries

Insulin prices are 8 times higher in the United States than 32 other high-income countries combined.

Health-System Specialty Pharmacies Address Social Determinants of Health

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.

NIH Funds First Nationwide Network to Study Rare Forms of Diabetes

The Rare and Atypical Diabetes Network (RADIANT) plans to screen approximately 2000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 diabetes (T1D) and type 2 diabetes (T2D).

The Pharmacy Times® Diabetes specialty page serves as a hub for all clinical news and articles related to the condition. The coverage includes best practices for treating diabetes, from the early signs and symptoms like increased thirst, fatigue, and blurred vision; and addresses the primary causes of diabetes – the destruction of insulin-producing beta cells of the pancreas.

The Pharmacy Times® Diabetes condition center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel diabetes therapies, and the newest data from all phases of clinical trials and studies in the space.